Personalis Inc
NASDAQ:PSNL

Watchlist Manager
Personalis Inc Logo
Personalis Inc
NASDAQ:PSNL
Watchlist
Price: 6.09 USD 2.35% Market Closed
Market Cap: 430.3m USD
Have any thoughts about
Personalis Inc?
Write Note

Personalis Inc
Investor Relations

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company is headquartered in Menlo Park, California and currently employs 325 full-time employees. The company went IPO on 2019-06-20. The firm is focused on the development of therapies by providing molecular data about each patient's cancer and immune response. The company provides sequencing and data analysis services to support the development of cancer therapies. Its NeXT Platform, which provides its biopharmaceutical customers with information on over 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover over 50 to 500 genes. Its NeXT Platform is designed to provide analysis of both a tumor and its immune microenvironment from a single limited tissue sample. Its platform covers the deoxyribonucleic acid sequence of all of the approximately 20,000 human genes. The company also reports on transcriptome of a tumor, which encompasses ribonucleic acid expression across human genes, allowing it to determine which of the genomic mutations might actually be driving tumor progression.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Christopher M. Hall
President, CEO & Director
No Bio Available
Mr. Aaron L. Tachibana
CFO & COO
No Bio Available
Mr. Stephen M. Moore J.D.
Senior VP & Chief Legal Officer
No Bio Available
Dr. Richard Chen M.D., M.S.
Executive VP of R&D and Chief Medical Officer
No Bio Available
Dr. Michael P. Snyder Ph.D.
Co-Founder and Member of Clinical & Scientific Advisory Board
No Bio Available
Mr. Michael J Fitzpatrick
Vice President of Worldwide Sales
No Bio Available
Dr. Christian Haudenschild Ph.D.
Senior Vice President of Genomic Laboratory Operations
No Bio Available
Mr. Stephane Mouradian Ph.D.
Senior Vice President of Business Development
No Bio Available

Contacts

Address
CALIFORNIA
Menlo Park
1330 Obrien Dr
Contacts
+16507521300.0
www.personalis.com